These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31918399)
1. New antifungal ent-labdane diterpenes against Candida glabrata produced by microbial transformation of ent-polyalthic acid. Pontes de Sousa I; Ferreira AG; Miller Crotti AE; Alves Dos Santos R; Kiermaier J; Kraus B; Heilmann J; Jacometti Cardoso Furtado NA Bioorg Chem; 2020 Jan; 95():103560. PubMed ID: 31918399 [TBL] [Abstract][Full Text] [Related]
2. Production of More Potent Anti-Candida Labdane Diterpenes by Biotransformation Using Cunninghamella elegans. Sousa IP; De Sousa Teixeira MV; Freitas JA; Ferreira AG; Pires LM; Santos RA; Heleno VCG; Furtado NAJC Chem Biodivers; 2022 Mar; 19(3):e202100757. PubMed ID: 35092349 [TBL] [Abstract][Full Text] [Related]
3. Ent-hardwickiic acid from C. pubiflora and its microbial metabolites are more potent than fluconazole in vitro against Candida glabrata. Sousa Teixeira MV; Fernandes LM; Stefanelli de Paula V; Ferreira AG; Jacometti Cardoso Furtado NA Lett Appl Microbiol; 2022 Apr; 74(4):622-629. PubMed ID: 34995375 [TBL] [Abstract][Full Text] [Related]
4. Production of new ent-hardwickiic acid derivatives by microbial transformation and their antifungal activity. Teixeira MVS; Fernandes LM; de Paula VS; Ferreira AG; Pires LM; Santos RA; Furtado NAJC Fitoterapia; 2024 Mar; 173():105810. PubMed ID: 38163448 [TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Candida biofilms to histatin 5 and fluconazole. Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514 [TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints. Chen YC; Kuo SF; Chen FJ; Lee CH Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210 [TBL] [Abstract][Full Text] [Related]
10. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843 [TBL] [Abstract][Full Text] [Related]
11. Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species. Butts A; Reitler P; Ge W; Fortwendel JR; Palmer GE Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712657 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates. Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097 [TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Pfaller MA; Castanheira M; Messer SA; Jones RN Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints]. Hazırolan G; Sarıbaş Z; Arıkan Akdağlı S Mikrobiyol Bul; 2016 Jul; 50(3):428-37. PubMed ID: 27525398 [TBL] [Abstract][Full Text] [Related]
16. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains. Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006 [TBL] [Abstract][Full Text] [Related]